Ionis Pharmaceuticals (Nasdaq: IONS) and partner Roche announced positive prespecified interim results from the ongoing Phase 3 IMAgINATION study evaluating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA